NCT00163111已完成3 期
A Randomized, Open Label, Comparative Multicenter Study Of Voriconazole Versus Conventional Amphotericin B Followed By Fluconazole In The Treatment Of Candidaemia In Non Neutropenic Subjects.
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Pfizer
- 入组人数
- 412
- 主要终点
- Sustained clinical response for 12 weeks from end of treatment
研究概览
简要总结
This is a study to investigate the safety and efficacy of voriconazole for the treatment of candidemia in critically ill non-neutropenic patients
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with candidemia
排除标准
- •Neutropenia
结局指标
主要结局
Sustained clinical response for 12 weeks from end of treatment
次要结局
- Time to negative blood cultures
研究者
相似试验
已完成
3 期
An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal InfectionsFungemiaMycosesCandidiasisAspergillosisNCT00001810National Cancer Institute (NCI)300
已完成
2 期
Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary AspergillosisAllergic Bronchopulmonary AspergillosisNCT01621321Post Graduate Institute of Medical Education and Research, Chandigarh50
终止
3 期
A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric PatientsCandidiasisNCT01092832Pfizer23
终止
3 期
A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In ChildrenInvasive AspergillosisNCT00836875Pfizer31
已完成
3 期
Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile-associated DiarrheaClostridium Difficile InfectionNCT01983683Actelion631